Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $21,430 | 13 | 82.7% |
| Food and Beverage | $3,249 | 242 | 12.5% |
| Travel and Lodging | $1,035 | 15 | 4.0% |
| Education | $191.02 | 5 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Pharmaceuticals America, Inc. | $10,984 | 19 | $0 (2017) |
| Takeda Pharmaceuticals U.S.A., Inc. | $10,248 | 36 | $0 (2021) |
| Allergan, Inc. | $2,675 | 76 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $635.21 | 65 | $0 (2021) |
| Lundbeck LLC | $397.29 | 24 | $0 (2021) |
| Neurocrine Biosciences, Inc. | $301.85 | 16 | $0 (2021) |
| Otsuka America Pharmaceutical, Inc. | $207.53 | 12 | $0 (2020) |
| Shire North American Group Inc | $129.50 | 8 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $82.18 | 3 | $0 (2019) |
| AbbVie Inc. | $58.81 | 4 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $259.27 | 19 | Takeda Pharmaceuticals U.S.A., Inc. ($115.39) |
| 2020 | $538.48 | 48 | Allergan, Inc. ($198.74) |
| 2019 | $8,168 | 81 | Takeda Pharmaceuticals U.S.A., Inc. ($7,326) |
| 2018 | $3,479 | 54 | Takeda Pharmaceuticals U.S.A., Inc. ($2,730) |
| 2017 | $13,461 | 73 | Takeda Pharmaceuticals America, Inc. ($10,984) |
All Payment Transactions
275 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/08/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $10.59 | General |
| Category: NEUROSCIENCE | ||||||
| 10/01/2021 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: NEUROLOGY | ||||||
| 09/15/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $11.43 | General |
| Category: NEUROSCIENCE | ||||||
| 09/09/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.50 | General |
| Category: NEUROSCIENCE | ||||||
| 07/02/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: NEUROSCIENCE | ||||||
| 07/02/2021 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: NEUROSCIENCE | ||||||
| 06/04/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: NEUROSCIENCE | ||||||
| 05/14/2021 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: NEUROLOGY | ||||||
| 05/05/2021 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $9.53 | General |
| Category: CNS | ||||||
| 04/30/2021 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: NEUROSCIENCE | ||||||
| 04/21/2021 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $4.99 | General |
| Category: CNS | ||||||
| 04/09/2021 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $20.33 | General |
| Category: PSYCHIATRY | ||||||
| 04/02/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: NEUROSCIENCE | ||||||
| 03/26/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: NEUROSCIENCE | ||||||
| 03/19/2021 | Eisai Inc. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $14.43 | General |
| Category: Neurology | ||||||
| 02/26/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: NEUROSCIENCE | ||||||
| 02/25/2021 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $7.04 | General |
| Category: CNS | ||||||
| 02/05/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: NEUROSCIENCE | ||||||
| 01/22/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: NEUROSCIENCE | ||||||
| 12/18/2020 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $12.13 | General |
| Category: NEUROSCIENCE | ||||||
| 12/11/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2020 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: NEUROSCIENCE | ||||||
| 11/25/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.66 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2020 | Lundbeck LLC | BRINTELLIX (Drug) | Food and Beverage | Cash or cash equivalent | $13.33 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 3 | 154 | 544 | $82,080 | $51,735 |
| 2020 | 3 | 210 | 716 | $107,715 | $58,335 |
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 130 | 515 | $77,250 | $48,644 | 63.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 12 | 17 | $3,570 | $2,330 | 65.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 12 | 12 | $1,260 | $761.30 | 60.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 168 | 666 | $99,900 | $53,995 | 54.0% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 19 | 25 | $5,190 | $2,940 | 56.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 23 | 25 | $2,625 | $1,400 | 53.3% |
About Dr. James Lizer, M.D
Dr. James Lizer, M.D is a Psychiatry healthcare provider based in Winchester, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1154333805.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Lizer, M.D has received a total of $25,905 in payments from pharmaceutical and medical device companies, with $259.27 received in 2021. These payments were reported across 275 transactions from 17 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($21,430).
As a Medicare-enrolled provider, Lizer has provided services to 364 Medicare beneficiaries, totaling 1,260 services with total Medicare billing of $110,070. Data is available for 2 years (2020–2021), covering 6 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Winchester, VA
- Active Since 08/12/2006
- Last Updated 07/08/2007
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1154333805
Products in Payments
- Trintellix (Drug) $20,921
- VRAYLAR (Drug) $2,719
- LATUDA (Drug) $635.21
- TRINTELLIX (Drug) $429.61
- INGREZZA (Drug) $301.85
- REXULTI (Drug) $300.10
- VYVANSE (Drug) $107.23
- ABILIFY MAINTENA (Drug) $63.24
- BRINTELLIX (Drug) $59.76
- MYDAYIS (Drug) $53.54
- SPRAVATO (Drug) $46.29
- NUEDEXTA (Drug) $41.42
- NUPLAZID (Drug) $32.57
- BELSOMRA (Drug) $31.19
- SUBOXONE SUBLINGUAL FILM (Drug) $20.31
- AUSTEDO (Drug) $17.96
- INVEGA SUSTENNA (Drug) $15.71
- Dayvigo (Drug) $14.43
- VIIBRYD (Drug) $14.20
- SD809-TD (Drug) $13.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Winchester
Malini Nair, Md, MD
Psychiatry — Payments: $519,902
Lakuma Mogili, Md, MD
Psychiatry — Payments: $3,589
Dr. Rauf Cheema, Md, MD
Psychiatry — Payments: $1,311
Dr. Surendra Kandel, M.d, M.D
Psychiatry — Payments: $694.04
Dr. Shabana Firdous, Md, MD
Psychiatry — Payments: $677.76
Dr. Bishnu Subedi, Md, MD
Psychiatry — Payments: $312.97